High prevalence of thyroid function test abnormalities in chronic schizophrenia

References

• Rubin R T, Poland R E, Lesser I M, Martin D J. Neuroendocrine aspects of primary endogenous depression. Pituitary-thyroid axis activity in patients and matched control subjects. Psychoneuro-endocrinology 1987; 12: 333–347
   PubMedGoogle Scholar
• Banki C M, Arato M, Papp Z. Thyroid stimulation test in healthy subjects and psychiatric patients. Acta Psychiatrica Scandinavica 1984; 70: 295–303
   PubMed Web of Science ®Google Scholar
• De Milo L. TRH response pattern in adolescent schizophrenic-males. British Journal of Psychiatry 1984; 145: 649–651
   PubMedGoogle Scholar
• Gold M S, Pottash A LC, Extein I. Symptomless auto-immune thyroiditis in depression. Psychiatry Research 1982; 6: 261–269
   PubMedGoogle Scholar
• Nemeroff C B, Simon J S, Haggerty J J, Evans D L. Antithyroid antibodies in depressed patients. American Journal of Psychiatry 1985; 142: 840–842
   PubMed Web of Science ®Google Scholar
• Rupprecht R, Rupprecht C, Rupprecht M, et al. Triiodothyronine, thyroxine and TSH response to dexamethasone in depressed patients and normal controls. Biological Psychiatry 1989; 25: 22–32
   PubMedGoogle Scholar
• Spitzer R L, Endicott J, Robins E. Research diagnostic criteria: rationale and reliability. Archives of General Psychiatry 1978; 36: 773–782
   Web of Science ®Google Scholar
• Ng M L, Goh K H, Rajna A, Khalid B AK. Development of ELISA kits for the measurement of autoantibodies. Proceedings of first seminar on biotechnology programmes, Z C Alang. Ministry of Science, Technology and Environment, Malaysia, Malaysia 1989; 18–19
   Google Scholar
• Ng M L, Goh K H, Nazaimoon Wan M.W, Thean E TT, Khalid B AK. Non-isotope in-house ELISA as an alternative to RIA/IRMA for measurement of pituitary peptide hormones. International Atomic Energy Agency in co-operation with the World Health Organisation, Vienna 26-30 August, 1991, Proceedings of international symposium on radioimmunoassay and related procedures: Perspectives in developing countries
   Google Scholar
• Siris S G, Frechen K, Strahan A, et al. Thyroid releasing hormone test in schizophrenic patients with post-psychotic depression. Progress in Neuropsychopharmacology and Biological Psychiatry 1991; 15: 369–78
   PubMed Web of Science ®Google Scholar
• Gross G, Strebel B, Braunig P, et al. Serum amino acids, central monoamines and hormones in drug naive, drug free and neuroleptic-treated schizophrenic patients and healthy subjects. Psychiatry Research 1990; 34: 243–57
   PubMedGoogle Scholar
• Martinos A, Rinieris P, Souvatzolou A, et al. Effects of six weeks' neuroleptic treatment on the pituitary-thyroid axis in schizophrenic patients. Neuropsychobiology 1986; 16: 72–77
   PubMedGoogle Scholar
• Haggerty J J, Dwight L E, Golden R N, Pedersen C A, Simon J S, Nemeroff C B. The presence of antithyroid antibodies in patients with affective and nonaffeclive psychiatric disorders. Biological Psychiatry 1990; 27: 51–60
   PubMed Web of Science ®Google Scholar
• Harris B, Othman S, Davies J A, et al. Association between postpartum thyroid dysfunction and thyroid antibodies and depression. British Medical Journal 1992; 305: 152–155
   PubMed Web of Science ®Google Scholar
• Tunbridge W MG, Evered D C, Hall R, et al. The spectrum of thyroid disease in a community: The Whickham survey. Clinical Endocrinology 1977; 7: 481–492
   PubMed Web of Science ®Google Scholar
• Okamura K, Nakashima T, Ueda K, et al. Thyroid disorders in the general population of Hisayama Japan, with special reference to prevalence and sex differences. International Journal of Epidemiology 1987; 16: 545–549
   PubMed Web of Science ®Google Scholar
• Calabreses J R, Kling A K, Gold P W. Alterations in immunocompetence during stress, bereavement and depression: Focus on neuroendocrine regulation. American Journal of Psychiatry 1987; 144: 1123–1134
   PubMedGoogle Scholar
• Fitzgerald L. Exercise and the immune system. Immunology Today 1988; 9: 337–339
   PubMedGoogle Scholar
• Edwards I CK, II, Ghiasuddin S M, Schepper J M, et al. A newly defined property of somatotropin: Priming of macrophages for production of superoxide anion. Science 1988; 239: 769–771
   PubMed Web of Science ®Google Scholar
• Tecoma E S, Huey Y H. Psychic distress and the immune response. Life Science 1985; 36: 1799–1812
   PubMed Web of Science ®Google Scholar
• Parshad O, Uppal A. Thyroid-gonad relationship in chronic schizophrenia. West Indian Medical Journal 1989; 38: 83–87
   PubMedGoogle Scholar
• Morley J E, Shafer R B. Thyroid function screening in new psychiatric admission. Archives of Internal Medicine 1982; 142: 591–593
   PubMedGoogle Scholar